Advertisement

< Back to Article

Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade

Figure 1

Eligibility decision tree for a US FDA priority review voucher.

Criteria are based on the FDA Draft Guidance for Industry: Tropical Disease Priority Review Vouchers.

Figure 1

doi: https://doi.org/10.1371/journal.pntd.0001803.g001